153 related articles for article (PubMed ID: 15598869)
21. Physiological roles and molecular mechanisms of K
Garneau AP; Marcoux AA; Slimani S; Tremblay LE; Frenette-Cotton R; Mac-Way F; Isenring P
J Physiol; 2019 Mar; 597(6):1451-1465. PubMed ID: 30659612
[TBL] [Abstract][Full Text] [Related]
22. Diet Bioactive Compounds: Implications for Oxidative Stress and Inflammation in the Vascular System.
Gabriele M; Pucci L
Endocr Metab Immune Disord Drug Targets; 2017 Nov; 17(4):264-275. PubMed ID: 28933306
[TBL] [Abstract][Full Text] [Related]
23. Nrf2 in aging - Focus on the cardiovascular system.
Kloska D; Kopacz A; Piechota-Polanczyk A; Nowak WN; Dulak J; Jozkowicz A; Grochot-Przeczek A
Vascul Pharmacol; 2019 Jan; 112():42-53. PubMed ID: 30170173
[TBL] [Abstract][Full Text] [Related]
24. Targets of oxidative stress in cardiovascular system.
Chakraborti T; Ghosh SK; Michael JR; Batabyal SK; Chakraborti S
Mol Cell Biochem; 1998 Oct; 187(1-2):1-10. PubMed ID: 9788737
[TBL] [Abstract][Full Text] [Related]
25. Does corticosteroid metabolism in target organs affect the cardiovascular system?
Hierholzer K; Lichtenstein I; Siebe H
J Auton Nerv Syst; 1996 Mar; 57(3):188-92. PubMed ID: 8964948
[TBL] [Abstract][Full Text] [Related]
26. Angiotensin type 1 and type 2 receptors during ontogeny: cardiovascular and renal effects.
Vinturache AE; Smith FG
Vascul Pharmacol; 2014 Dec; 63(3):145-54. PubMed ID: 25451565
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular dopamine receptors: role of renal dopamine and dopamine receptors in sodium excretion.
Lokhandwala MF; Hegde SS
Pharmacol Toxicol; 1990 Apr; 66(4):237-43. PubMed ID: 2196552
[TBL] [Abstract][Full Text] [Related]
28. The role of oxidative stress in renovascular hypertension.
Campos RR; Oliveira-Sales EB; Nishi EE; Boim MA; Dolnikoff MS; Bergamaschi CT
Clin Exp Pharmacol Physiol; 2011 Feb; 38(2):144-52. PubMed ID: 20678153
[TBL] [Abstract][Full Text] [Related]
29. Proinflammatory cytokines and ageing of the cardiovascular-renal system.
Smykiewicz P; Segiet A; Keag M; Żera T
Mech Ageing Dev; 2018 Oct; 175():35-45. PubMed ID: 30031888
[TBL] [Abstract][Full Text] [Related]
30. Iron, oxidative stress, and redox signaling in the cardiovascular system.
Gudjoncik A; Guenancia C; Zeller M; Cottin Y; Vergely C; Rochette L
Mol Nutr Food Res; 2014 Aug; 58(8):1721-38. PubMed ID: 24888568
[TBL] [Abstract][Full Text] [Related]
31. Responses to reductive stress in the cardiovascular system.
Handy DE; Loscalzo J
Free Radic Biol Med; 2017 Aug; 109():114-124. PubMed ID: 27940350
[TBL] [Abstract][Full Text] [Related]
32. AT2 receptors in cardiovascular and renal diseases.
Kaschina E; Namsolleck P; Unger T
Pharmacol Res; 2017 Nov; 125(Pt A):39-47. PubMed ID: 28694144
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular Toxicity of Cyclooxygenase Inhibitors and Promising Natur a l Substitutes.
Bahmani M; Sarrafchi A; Shirzad H; Asgari S; Rafieian-Kopaei M
Curr Pharm Des; 2017; 23(6):952-960. PubMed ID: 27719647
[TBL] [Abstract][Full Text] [Related]
34. An overview of the mechanisms and novel roles of Nrf2 in cardiovascular diseases.
Jiang S; Yang Y; Li T; Ma Z; Hu W; Deng C; Fan C; Lv J; Sun Y; Yi W
Expert Opin Ther Targets; 2016 Dec; 20(12):1413-1424. PubMed ID: 27756179
[TBL] [Abstract][Full Text] [Related]
35. Endothelin.
Granger JP
Am J Physiol Regul Integr Comp Physiol; 2003 Aug; 285(2):R298-301. PubMed ID: 12855412
[No Abstract] [Full Text] [Related]
36. Co-expression of urotensin II and its receptor (GPR14) in human cardiovascular and renal tissues.
Matsushita M; Shichiri M; Imai T; Iwashina M; Tanaka H; Takasu N; Hirata Y
J Hypertens; 2001 Dec; 19(12):2185-90. PubMed ID: 11725162
[TBL] [Abstract][Full Text] [Related]
37. L-arginine or tempol supplementation improves renal and cardiovascular function in rats with reduced renal mass and chronic high salt intake.
Carlström M; Brown RD; Yang T; Hezel M; Larsson E; Scheffer PG; Teerlink T; Lundberg JO; Persson AE
Acta Physiol (Oxf); 2013 Apr; 207(4):732-41. PubMed ID: 23387940
[TBL] [Abstract][Full Text] [Related]
38. Thioredoxin: a key regulator of cardiovascular homeostasis.
Yamawaki H; Haendeler J; Berk BC
Circ Res; 2003 Nov; 93(11):1029-33. PubMed ID: 14645133
[TBL] [Abstract][Full Text] [Related]
39. Cyclophilin A in cardiovascular homeostasis and diseases.
Satoh K
Tohoku J Exp Med; 2015 Jan; 235(1):1-15. PubMed ID: 25743766
[TBL] [Abstract][Full Text] [Related]
40. Oxidative Stress and Kidney Function: A Brief Update.
Coppolino G; Leonardi G; Andreucci M; Bolignano D
Curr Pharm Des; 2018; 24(40):4794-4799. PubMed ID: 30648504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
